Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

New study compares polymer and polymer-free drug-eluting stents after 3 years

The analysis included outcomes data from nearly 1,500 PCI patients. 

Q&A: Cleveland Clinic cardiologist details the past, present and future of drug-eluting stents

Amar Krishnaswamy, MD, shared his thoughts on this important technology in an exclusive interview. 

Thumbnail

PAD specialists announce new FDA clearance for image-guided atherectomy system

The solution is now cleared as a treatment option for in-stent restenosis in the lower extremity arteries.

We may finally know why type 2 diabetes is associated with vascular damage

New research published in Diabetes provides some potential answers to a big question. 

New survey examines the biggest issues impacting care for CAD, PAD patients

Physicians, industry leaders—and, yes, patients themselves—provided an updated look at the state of vascular care in 2021. 

dollar money graph increase finance

Hispanic PAD patients often face longer hospitalizations, higher costs

Hispanic adults with peripheral artery disease tend to seek care through the emergency department—and they are paying the price.

‘Saving lives and saving limbs’: New study of real-world CMS patients highlights the benefits of IVUS

The Smith Center for Outcomes Research in Cardiology examined real-world data from more than 700,000 CMS patients. The group's findings were presented during TCT 2021. 

Thumbnail

Tracking sac regression after endovascular aneurysm repair for AAA

Researchers pointed to the importance of tracking long-term patient outcomes related to EVAR for AAA.